Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-GWEPDDNPI-OH
3D-Ansicht

Biosynth logo

H-GWEPDDNPI-OH

Ref. 3D-PP43614

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-GWEPDDNPI-OH
Synonyme:
  • NH2-Gly-Trp-Glu-Pro-Asp-Asp-Asn-Pro-Ile-OH
Beschreibung:

Peptide H-GWEPDDNPI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GWEPDDNPI-OH include the following: A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression XT Song , KE Kabler, L Shen, L Rollins, XF Huang - Nature medicine, 2008 - nature.comhttps://www.nature.com/articles/nm1721 Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity V Rigo, MV Corrias, AM Orengo, A Brizzolara - Cancer Immunology , 2014 - Springerhttps://link.springer.com/article/10.1007/s00262-014-1536-9 Survivin minigene DNA vaccination is effective against neuroblastoma S Fest, N Huebener, M Bleeke - journal of cancer, 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.24291 Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity RR Servin-Garrido - Cancer: Basic and , 2022 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/11782234211065154 Treat cancers by targeting survivin: just a dream or future reality? MS Coumar , FY Tsai, JR Kanwar , S Sarvagalla - Cancer treatment , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737213000339 Checkpoint blockade in combination with cancer vaccines MA Morse, HK Lyerly - Vaccine, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X15014723 Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen M Croce , R Meazza, AM Orengo, M Fabbi - Cancer Immunology , 2008 - Springerhttps://link.springer.com/article/10.1007/s00262-008-0496-3 Neuroblastoma: Perspectives for the Use of IL-21 in Immunotherapy M Croce , MV Corrias, S Ferrini - Neuroblastoma: Diagnosis, Therapy, and , 2012 - Springerhttps://link.springer.com/chapter/10.1007/978-94-007-2418-1_12 Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models K Zhu, H Qin, SC Cha, SS Neelapu , W Overwijk - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X07009929 Aedes aegypti midgut DNA synthesis de novo is an essential antiviral strategy against dengue virus serotype 2 replication J Serrato - IMMUNO MEXICO 2018 - academia.eduhttps://www.academia.edu/download/108101289/ALAI_SMI_IMUNOMEXICO_2018.pdf#page=1030 Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma model EL Williams, SN Dunn, S James, PW Johnson - Clinical cancer , 2013 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/19/13/3545/207430 Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha E Balza , B Carnemolla, L Mortara - journal of cancer, 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.25018 STING Ligand c-di-GMP Improves Cancer Vaccination D Chandra, AJ Wilber Quispe-Tintaya - academia.eduhttps://www.academia.edu/download/35121430/Chandra_STING_ligand_improve_cancer_vaccine.pdf STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer D Chandra , W Quispe-Tintaya , A Jahangir - Cancer immunology , 2014 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/2/9/901/467559 Excreted/secreted products from a helminth parasite inhibits tumorigenesis on the early stages of colitis associated colorectal cancer BEC Piaca±a, SR Martaca­nez, I Chavez, CDacaSB Soto - IMMUNO MEXICO - researchgate.nethttps://www.researchgate.net/profile/Elizabeth_Salinas_Estrella/publication/328389976_Antibodies_generated_against_bovine_CD205_using_a_bioinformatics_approach/links/5bca0548458515f7d9cb8310/Antibodies-generated-against-bovine-CD205-using-a-bioinformatics-approach.pdf#page=1042 Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of A NoeDominguez-Romero - Human Vaccines & , 2014 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/hv.29679 Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms A Jahangir , D Chandra , W Quispe-Tintaya - , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2017.1342025 Therapy with multi-epitope virus-like particles of B19 parvovirus reduce tumor growth and lung metastasis in an aggressive breast cancer mouse model A de Jesus Jimenez-Chavez , L Moreno-Fierros - Vaccine, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X19312964

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP43614 H-GWEPDDNPI-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.